Skip to content

Kobayashi Kako

Request correction

A pharmaceutical company headquartered in Awara City, Fukui Prefecture, Japan.

Last updated September 1, 2026

AI crawler reads

4requests

1companies
  • Anthropic4
Profile
2
Controversies
2
JSON · MD
0
First read
Nov 4, 2026
Latest read
Nov 4, 2026

From this site's server log

Overview

Kobayashi Kako is a pharmaceutical company headquartered in Awara City, Fukui Prefecture, Japan. According to its official website, the company abolished its pharmaceutical manufacturing and sales license as of April 1, 2023, after conducting drug price deletions and approval consolidations for pharmaceuticals for which it held manufacturing and marketing approvals.

History

Kobayashi Kako is a pharmaceutical company headquartered in Awara City, Fukui Prefecture, Japan. According to its official website, the company conducted drug price deletions and approval consolidations for pharmaceuticals for which it held manufacturing and marketing approvals, and abolished its pharmaceutical manufacturing and sales license as of April 1, 2023.

Controversies

  • 2021

    Kobayashi Kako admits drug manufacturing irregularities

    Kobayashi Kako admitted that irregular operations led to a key ingredient in oral antifungal medicines being replaced with a sleep-inducing ingredient, at 2.5 times Japan's maximum limit. The article also reports that more than 200 patients experienced health problems after taking the company's medicines.

Read more

Recent events

  • Unconfirmed

    Reported

    Authorities order Kobayashi Kako to suspend operations for 116 days[3]

    Local authorities ordered Kobayashi Kako to suspend operations for 116 days, according to the article.

  • Unconfirmed

    Reported

    Kobayashi Kako admits drug manufacturing irregularities[3]

    Kobayashi Kako admitted that irregular operations led to a key ingredient in oral antifungal medicines being replaced with a sleep-inducing ingredient, at 2.5 times Japan's maximum limit. The article also reports that more than 200 patients experienced health problems after taking the company's medicines.

Read more

Sources3 sources

Cite this profile: Cite the canonical profile. /brand-wiki/kobayashi-kako · Editorial policy · How profiles are compiled